Journal of Clinical Investigation· 2026Q1
UA-30 ameliorates motor deficits through RalA-mediated mitophagy in ALS mice
- 0citations
- Q1SCImago
- 2026year
Short summary
A new drug, UA-30, extended lifespan and improved motor function in ALS mice by enhancing mitophagy through RalA inhibition.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Neurology (Medicine)
NeurologyMedicine